beta-alanylhistamine,
carcinine,
Carcinine,
56897-53-1,
N-(2-(1H-Imidazol-5-yl)ethyl)-3-aminopropanamide,
beta-Alanylhistamine,
UNII-WIV0W167TC,
WIV0W167TC,
N-[2-(1H-imidazol-5-yl)ethyl]-beta-alaninamide,
3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide,
SPBio_002343,
beta-alaninylhistamine,
N-beta-alanylhistamine,
AC1L1DZE,
Prestwick0_000422,
Prestwick1_000422,
Prestwick2_000422,
Prestwick3_000422,
Lopac-C-2321,
AC1Q5P6Q,
n-[2-(1h-imidazol-5-yl)ethyl]-|A-alaninamide,
Lopac0_000210,
BSPBio_000404,
KSC921E6R,
MLS002153803,
BPBio1_000446,
CHEMBL461024,
SCHEMBL2819350,
SCHEMBL19051459,
CHEBI:95262,
CTK8C1268,
DTXSID90205421,
CHEBI:131429,
HMS1569E06,
HMS2096E06,
HMS2235I06,
HMS3371N06,
ANW-66135,
ZINC29747055,
AKOS006271690,
AKOS013465881,
CCG-204305,
SMP2_000161,
NCGC00015221-01,
NCGC00015221-02,
NCGC00015221-03,
AK-84422,
SMR001233178,
AX8223359,
CAS-56897-53-1,
RT-003724,
4CH-021715,
N-[2-(1H-imidazol-4-yl)ethyl]-beta-alaninamide,
Propanamide, 3-amino-N-(2-(1H-imidazol-4-yl)ethyl)-,
HJD,
Carcinine hydrochloride,
Carcinine dihydrochloride,
Carcinine ditrifluoroacetate,
D06ZBV,
CID2574,
C8-H14-N4-O,
AR-1K3531,
19226-03-0,